临床诊断

路明克斯公司的xTAG™ 和 MultiCode®-RTx 技术灵敏度及准确性高,应用领域广泛,适用于高通量及高速度的检测。
 
 
 
了解更多

科学研究

您对自行研发以满足实验需求及技术指标感兴趣吗?路明克斯公司的xMAP®技术可以为您的多重检测提供一个灵活及应用广泛的平台。
 
 
 
了解更多

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
了解更多

Luminex Blog

How Luminex Is Supporting Research Partners’ Pandemic Response

Licensed Technologies Group is finding new ways to boost partner programs

Our Licensed Technologies Group (LTG), which works closely with our many research partners to help develop assays and services based on xMAP® Technology, has pivoted to be more involved in coronavirus efforts. Employees in this area are used to traveling all the time to visit partners. Now, the whole team is working from home and finding new ways to help colleagues in other organizations who are involved in characterizing the COVID-19 immune response, studying disease progression, developing serology tests or vaccine candidates, and more.

Continue Reading >

xMAP TECHNOLOGY OVERVIEW

 

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Luminex on Twitter


#xMAP Technology generates data from potentially hundreds of targets per sample, even when there’s very little samp… https://t.co/HAt0J9ucfd
h J R
Grab your coffee and get ready to join us for a virtual chat with @BioRad experts about #multiplex immunoassays in… https://t.co/hauogQjdHw
h J R
Want to learn more about our xMAP® multiplex, high-throughput immunoassays or how the Guava® & Amnis® flow cytomete… https://t.co/2vUhyRENKQ
h J R

Latest News

May 22nd
Luminex Corporation Declares Second Quarter Cash Dividend

May 8th
Luminex Corporation Announces Pricing Of Offering Of $260 Million Of 3.00% Convertible Senior Notes Due 2025

May 4th
Luminex Corporation Reports First Quarter 2020 Results

April 22nd
Luminex Corporation First Quarter Earnings Release Rescheduled for May 4, 2020

Events

Coronavirus Virtual Webinar Series
June 17th
Virtual

International Society for Extracellular Vesicles (ISEV) Annual Meeting
July 20-22
Virtual